2025-04-01 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Review

**0. Overview:** Intuitive Surgical Inc. is a leading medical device company focused on minimally invasive surgery using its da Vinci Surgical System.

**1. Performance vs. S&P 500 (VOO):**

ISRG's cumulative return is significantly higher than that of the S&P 500 (VOO).

* **ISRG Cumulative Return:** 222.60%
* **VOO Cumulative Return:** 91.19%
* **Return Difference:** 131.41%  (This represents a substantial outperformance of the S&P 500.)
* **Relative Divergence:** 81.2% (Indicates ISRG's performance is in the upper 81.2 percentile of its historical performance relative to the S&P 500.)

The provided Alpha and Beta data shows inconsistent performance relative to the market (S&P500). While the CAGR is generally high, Alpha fluctuates, suggesting periods of outperformance and underperformance relative to the market risk. Beta is consistently high, indicating significant market sensitivity.  The substantial increase in market capitalization over the analyzed period further supports this growth.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 66.0% | 10.1% | -0.1 | 42.1 |
| 2016-2018  | 77.0% | 49.6% | -0.1 | 55.3 |
| 2017-2019  | 82.0% | 49.6% | 0.2 | 68.3 |
| 2018-2020  | 53.0% | 49.6% | 0.3 | 94.5 |
| 2019-2021  | 100.0% | 18.4% | 0.3 | 124.5 |
| 2020-2022  | 17.0% | 53.7% | 0.3 | 91.9 |
| 2021-2023  | 19.0% | 55.0% | 0.9 | 116.9 |
| 2022-2024  | 103.0% | 55.0% | 0.9 | 180.8 |
| 2023-2025  | 133.0% | 55.0% | 0.8 | 175.9 |


**2. Recent Price Movement:**

* **Closing Price:** $507.90
* **Last Market Price:** $491.37 (a slight decrease from the previous close)
* **5-Day Moving Average:** $507.56
* **20-Day Moving Average:** $512.61
* **60-Day Moving Average:** $554.05

The price is currently below its 5-day, 20-day, and 60-day moving averages, suggesting a short-term downward trend.  The recent small price drop (-0.1) is not significant enough to be considered a sharp decline.


**3. Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4283 (Medium Risk)
* **RSI:** 46.19 (Approaching oversold territory, but not yet definitively so)
* **PPO:** 0.6283 (Positive, indicating upward momentum)
* **20-Day Relative Divergence Change:** +1.8 (Indicates short-term upward trend)
* **Expected Return (2+ years):** 24.3% (This represents a significant outperformance expectation compared to the S&P 500 over the long term.)

**4. Recent Earnings Analysis:**

The provided earnings data shows relatively consistent revenue growth with some fluctuation in EPS.  The duplicate entry for 2024-10-18 needs clarification to ensure data accuracy.  Further analysis requires more detailed information, such as a comparison to analyst estimates and industry benchmarks.

| 날짜       | EPS  | 매출        |
|------------|------|-------------|
| 2024-10-18 | 1.59 | $2.04B      |
| 2024-07-19 | 1.48 | $2.01B      |
| 2024-04-19 | 1.54 | $1.89B      |
| 2023-10-20 | 1.18 | $1.74B      |
| 2024-10-18 | 1.18 | $1.74B      | *(Duplicate entry - requires clarification)*


**5. Financial Information:**

Both revenue and profitability indicators show consistent and strong performance.  Equity is steadily growing, although ROE fluctuates, suggesting some variability in profitability efficiency.  More detailed analysis would require comparing these figures to industry averages and past performance trends.

**Revenue and Profitability:**

| Quarter     | Revenue  | Profit Margin |
|-------------|----------|---------------|
| 2024-12-31 | $2.41B   | 68.04%        |
| 2024-09-30 | $2.04B   | 67.41%        |
| 2024-06-30 | $2.01B   | 68.30%        |
| 2024-03-31 | $1.89B   | 65.87%        |
| 2023-12-31 | $1.93B   | 66.24%        |

**Capital and Profitability:**

| Quarter     | Equity     | ROE    |
|-------------|------------|--------|
| 2024-12-31 | $16.43B    | 4.17%  |
| 2024-09-30 | $15.58B    | 3.63%  |
| 2024-06-30 | $14.71B    | 3.58%  |
| 2024-03-31 | $13.96B    | 3.90%  |
| 2023-12-31 | $13.31B    | 4.56%  |


**6.  Summary:**

ISRG has demonstrated a strong historical performance significantly outpacing the S&P 500.  While recent price action shows a slight downward trend, the long-term outlook, supported by a high expected return and generally strong financial performance, remains positive.  However, the high beta highlights the stock's sensitivity to market fluctuations.  Further investigation into the duplicate earnings data and comparison to industry benchmarks is recommended for a complete assessment.  The high relative divergence, coupled with the expected long-term return, makes ISRG an interesting prospect for long-term investors with a high-risk tolerance.
